Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT05826665

Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

Led by Kansas City Heart Rhythm Research Foundation · Updated on 2024-10-16

200

Participants Needed

4

Research Sites

95 weeks

Total Duration

On this page

Sponsors

K

Kansas City Heart Rhythm Research Foundation

Lead Sponsor

K

Kansas City Heart Rhythm Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard FDA cleared catheters and devices. This study aims to examine the impact of the STAR Apollo Mapping System on procedural and acute outcomes in a multicenter observational study.

CONDITIONS

Official Title

Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Indication for ablation of persistent AF
  • Age over 18 years
  • Persistent AF lasting more than 7 days and less than 2 years
  • Previous pulmonary vein isolation with AF recurrence
  • Limited additional ablation at first procedure (e.g. right atrial flutter line)
Not Eligible

You will not qualify if you...

  • Previous ablation in more than one region of the left atrium besides pulmonary veins
  • Longstanding persistent AF lasting more than 2 years or significant heart issues (mitral valve disease, scarring, very enlarged atria over 50mm)
  • Creatinine clearance less than 30 ml/min
  • Contraindication to anticoagulation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

St.Bernards Medical Center

Jonesboro, Arkansas, United States, 72401

Not Yet Recruiting

2

Sarasota Medical Center

Sarasota, Florida, United States, 34239

Actively Recruiting

3

Kansas City Heart Rhythm Institute - Roe Clinic

Overland Park, Kansas, United States, 66211

Not Yet Recruiting

4

Overland Park Regional Medical Center

Overland Park, Kansas, United States, 66215

Actively Recruiting

Loading map...

Research Team

D

Donita Atkins

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here